Spots Global Cancer Trial Database for excision of the primary lesion
Every month we try and update this database with for excision of the primary lesion cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
A Study of Neoadjuvant Therapy With BCD-217 (Nurulimab + Prolgolimab) in Patients With Resectable Stage III Skin Melanoma | NCT05751928 | Melanoma Stage ... Melanoma (Skin) | BCD-217 anti-PD1 Excision of the... Regional lympha... | 18 Years - | Biocad | |
A Study of Neoadjuvant Therapy With BCD-217 (Nurulimab + Prolgolimab) in Patients With Resectable Stage III Skin Melanoma | NCT05751928 | Melanoma Stage ... Melanoma (Skin) | BCD-217 anti-PD1 Excision of the... Regional lympha... | 18 Years - | Biocad |